Skip to main content
Clinical Trials/JPRN-UMIN000043899
JPRN-UMIN000043899
Completed
未知

A Multicenter Study on Biomarker Development Utilizing AI Multiomics for Patients with Advanced Solid Malignant Tumors - SCRUM-Japan MONSTAR-SCREEN-2

ational Cancer Center Hospital East0 sites2,768 target enrollmentApril 12, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
Advanced Solid Malignancies
Sponsor
ational Cancer Center Hospital East
Enrollment
2768
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 12, 2021
End Date
March 31, 2027
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Cancer Center Hospital East

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Has a history of undergoing allogeneic hematopoietic stem cell transplantation or organ transplantation. 2\.Is pregnant. 3\.Has a history of another malignant tumor within the three years prior to enrollment. 4\.Is judged to be ineligible for enrollment in this research by the study doctor.

Outcomes

Primary Outcomes

Not specified

Similar Trials